Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    Open Studies | "Urticaria"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Sustained Effect of Urticaria Remission With Relatively High Dose Vitamin D Supplementation After Omalizumab Discontinuation
Condition: Urticaria
Interventions: Dietary Supplement: Vitamin D (4,000 IU/day);   Dietary Supplement: Vitamin D (400 IU/day);   Drug: Omalizumab
2 Recruiting Monitoring Chronic Urticaria Basophil Irritability by Cytometry
Condition: Urticaria
Intervention: Other: Basophil patterns
3 Recruiting High Dose Vitamin D Supplementation in Chronic Spontaneous Urticaria
Condition: Urticaria
Interventions: Drug: Vitamin D3 (High dose);   Drug: Vitamin D3 (Low dose)
4 Recruiting AWARE - Chronic Urticaria
Condition: Chronic Urticaria
Intervention:
5 Recruiting Chronic Urticaria - Long Term Assessment of Effects of Rupatadine
Condition: Chronic Urticaria
Interventions: Drug: 10 mg Rupatadine on demand;   Drug: 10 mg Rupatadine;   Drug: 20 mg Rupatadine;   Drug: 10 mg Rupatadine on demand (sham updosing to 20 mg)
6 Not yet recruiting Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria
Condition: Acute Urticaria
Interventions: Drug: Test Drug (JDP-205);   Drug: Active Control (Diphenhydramine)
7 Not yet recruiting Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria
Condition: Chronic Spontaneous Urticaria
Interventions: Drug: Levocetirizine (as levocetirizine dihydrochloride), 5mg ( then 20 mg) per day . Oral administration.;   Drug: Levocetirizine, (as levocetirizine dihydrochloride) 20 mg ( then 5 mg) per day. Oral administration.
8 Recruiting Cold Contact Urticaria Treatment With Rilonacept
Condition: Cold Contact Urticaria
Interventions: Drug: Rilonacept;   Drug: Placebo
9 Recruiting Efficacy Study of Canakinumab to Treat Urticaria
Condition: Chronic Idiopathic Urticaria
Interventions: Drug: Canakinumab;   Drug: Placebo
10 Recruiting A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients
Condition: Chronic Spontaneous Urticaria
Intervention: Biological: QGE031
11 Recruiting Three-month, Single-center Study to Identify Biomarkers/Response to Xolair Therapy in Chronic Idiopathic Urticaria
Condition: Chronic Idiopathic Urticaria
Intervention: Biological: Xolair
12 Recruiting Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264
Condition: Urticaria
Interventions: Drug: GSK2646264 0.5% topical cream;   Drug: GSK2646264 1% topical cream;   Drug: Placebo
13 Recruiting Dietary Treatment for Chronic Urticaria
Conditions: Diet Modification;   Chronic Urticaria
Interventions: Other: Treatment group (on low histamine diet);   Other: Well-balanced diet
14 Recruiting Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU
Condition: Chronic Spontaneous Urticaria
Interventions: Biological: QGE031;   Biological: Omalizumab;   Other: Placebo
15 Recruiting Pathogenesis of Physical Induced Urticarial Syndromes
Conditions: Autoinflammatory Syndromes;   Physical Urticaria
Intervention:
16 Recruiting Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand
Conditions: Allergic Rhinitis;   Non-allergic Rhinitis;   Chronic Urticaria
Intervention:
17 Not yet recruiting Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria
Conditions: Urticaria;   Autoimmune Diseases;   Immune System Diseases;   Skin Diseases
Intervention: Biological: Autologous mesenchymal stem cell
18 Recruiting The Role of the Coagulation Pathways in Recurrent Angioedema
Condition: Chronic Spotaneous Urticaria, Idiopathic Non Histaminergic Angioderma, Hereditary Angioedema With C1 Inhibitor Deficiency
Intervention: Other: BLOOD TEST
19 Not yet recruiting Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations
Conditions: Urticaria Pigmentosa;   Cutaneous Mastocytosis
Interventions: Other: skin biopsy;   Other: blood draw
20 Recruiting Bococizumab HIV Evaluation (B-HIVE) Study
Conditions: Dyslipidemia;   Cardiovascular Disease
Interventions: Drug: Bococizumab;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.